Application of Prognostic Models Based on Psoas Muscle Index, Stage, Pathological Grade, and Preoperative Carcinoembryonic Antigen Level in Stage II-III Colorectal Cancer Patients Undergoing Adjuvant Chemotherapy

Figure 4

Evaluation of the prognostic in predicting patients’ RFS. (a) KM analysis; (b) 1-year ROC; (c) 3-year ROC; (d) 5-year ROC; (e): heatmap; (f) risk score distribution map; (g) recurrence state distribution map.

(a)

(b)

(c)

(d)

(e)

(f)

(g)